VRTX stock pitch - 2021-07-05

Added to YB: 2021-07-05

Pitch date: 2021-07-05

Vertex Pharmaceuticals Incorporated

current return

Author Info

No bio for this author

Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium

Company Info

Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally.

Market Cap

$119.5B

Pitch Price

$201.47

Price Target

N/A

Dividend

N/A

EV/EBITDA

21.37

P/E

30.70

EV/Sales

9.10

Sector

Biotechnology

A summary for this pitch has not been created yet.